Who Owns Seres Therapeutics Stock?
NASDAQ: MCRBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 3:59 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 22.93%
- Held by insiders
- 11.49%
- Institutional holders
- 46
- Institutions 22.9%
- Insiders 11.5%
- Public and other 65.6%
Who owns Seres Therapeutics stock?
Institutional investors own about 22.9% of Seres Therapeutics's shares, spread across 46 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 11.49% of MCRB.
The largest institutional holders are Flagship Pioneering LLC (11.51%), Vanguard Capital Management LLC (2.86%) and Marshall Wace LLP (1.71%). Together, the top 10 institutions control 20.9% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their MCRB positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of MCRB
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Flagship Pioneering LLC | 1.16M | 11.51% | 0.0% |
| Vanguard Capital Management LLC | 287.78K | 2.86% | -2.2% |
| Marshall Wace LLP | 172.25K | 1.71% | +23.4% |
| Vontobel Holding Limited | 122.97K | 1.22% | -11.2% |
| Blackrock Inc. | 111.00K | 1.11% | +8.8% |
| Geode Capital Management, LLC | 79.97K | 0.80% | +6.9% |
| Susquehanna International Group, LLP | 58.33K | 0.58% | -44.6% |
| Vanguard Fiduciary Trust Co | 48.69K | 0.48% | +22.8% |
| State Street Corporation | 33.90K | 0.34% | 0.0% |
| Lion Point Capital, LP | 31.57K | 0.31% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of MCRB
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 206.17K | 2.05% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 75.85K | 0.76% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 36.63K | 0.36% |
| SCHWAB STRATEGIC TRUST-Schwab U.S. Small-Cap ETF | 31.08K | 0.31% |
| iShares Trust-iShares Micro-Cap ETF | 25.22K | 0.25% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 13.87K | 0.14% |
| Invesco Exchange-Traded Fund Trust-Invesco RAFI US 1500 Small-Mid ETF | 12.91K | 0.13% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 10.14K | 0.10% |
| GOLDMAN SACHS TRUST-Goldman Sachs Absolute Return Tracker Fund | 10.06K | 0.10% |
| DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Micro Cap Portfolio | 7.66K | 0.08% |
Frequently asked questions
Who is the largest shareholder of Seres Therapeutics?
Flagship Pioneering LLC is the largest institutional shareholder of MCRB, owning 11.51% of shares outstanding (1.16M shares) as of its latest 13F filing.
What percentage of Seres Therapeutics is owned by institutions?
Institutions own about 22.9% of MCRB shares and 25.9% of the public float.
How much of Seres Therapeutics do insiders own?
Insiders, such as officers and directors, own about 11.49% of MCRB shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.